Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses.

Alexander Domnich, Ilaria Manini, Giovanna Elisa Calabrò, Chiara Waure, Emanuele Montomoli
Author Information
  1. Alexander Domnich: Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
  2. Ilaria Manini: Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.
  3. Giovanna Elisa Calabrò: Section of Hygiene, Institute of Public Health, Università Cattolica del Sacro Cuore, Largo Francesco Vito 1, 00168 Rome, Italy.
  4. Chiara Waure: Department of Experimental Medicine, University of Perugia, Piazza Lucio Severi 1, 06132 Perugia, Italy.
  5. Emanuele Montomoli: Department of Molecular and Developmental Medicine, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.

Abstract

Seasonal influenza is the leading infectious disease in terms of its health and socioeconomic impact. Annual immunization is the most efficient way to reduce this burden. Several correlates of influenza vaccine-induced protection are commonly used, owing to their ready availability and cheapness. Influenza vaccine-induced immunogenicity is a function of host-, virus- and vaccine-related factors. Host-related factors constitute the most heterogeneous group. The objective of this study was to analyze the available systematic evidence on the host factors able to modify influenza vaccine-induced immunogenicity. An umbrella review approach was undertaken. A total of 28 systematic reviews/meta-analyses were analyzed-these covered the following domains: intravenous drug use, psychological stress, acute and chronic physical exercise, genetic polymorphisms, use of pre-/pro-/symbiotics, previous Bacillus Calmette-Guérin vaccination, diabetes mellitus, vitamin D supplementation/deficiency, latent cytomegalovirus infection and various forms of immunosuppression. In order to present effect sizes on the same scale, all possible meta-analyses were re-performed and cumulative evidence synthesis ranking was carried out. The meta-analysis was conducted separately on each health condition category and virus (sub)type. A total of 97 pooled estimates were used in order to construct an evidence-based stakeholder-friendly map. The principal public health implications are discussed.

Keywords

References

  1. Vaccine. 2018 Aug 28;36(36):5350-5357 [PMID: 28774561]
  2. Vaccine. 2018 Jan 4;36(2):207-213 [PMID: 28923425]
  3. BMJ. 2017 Sep 21;358:j4008 [PMID: 28935701]
  4. PLoS One. 2011;6(12):e29249 [PMID: 22216224]
  5. BMC Med Res Methodol. 2016 Jan 05;16:1 [PMID: 26728979]
  6. BMC Med Res Methodol. 2007 Feb 15;7:10 [PMID: 17302989]
  7. Nutrients. 2017 Oct 27;9(11):null [PMID: 29077061]
  8. J Infect Dis. 2012 Oct;206(8):1250-9 [PMID: 22904335]
  9. Brain Behav Immun. 2009 May;23(4):427-33 [PMID: 19486657]
  10. Vaccine. 2012 Feb 14;30(8):1413-24 [PMID: 22197580]
  11. Cochrane Database Syst Rev. 2013 Aug 01;(8):CD006484 [PMID: 23904194]
  12. Cancers (Basel). 2011 Aug 12;3(3):3279-330 [PMID: 24212956]
  13. Dig Dis Sci. 2015 Aug;60(8):2446-53 [PMID: 25796579]
  14. Nature. 2003 Mar 27;422(6930):428-33 [PMID: 12660783]
  15. Saudi J Kidney Dis Transpl. 2015 Sep;26(5):877-83 [PMID: 26354557]
  16. Vaccines (Basel). 2017 Jul 18;5(3):null [PMID: 28718786]
  17. Drug Des Devel Ther. 2018 Jan 25;12:217-230 [PMID: 29416317]
  18. Wkly Epidemiol Rec. 2012 Nov 23;87(47):461-76 [PMID: 23210147]
  19. Expert Rev Vaccines. 2016 Aug;15(8):967-76 [PMID: 26954563]
  20. Pediatr Infect Dis J. 2011 Dec;30(12):1081-5 [PMID: 21983214]
  21. Clin Microbiol Rev. 2019 Mar 13;32(2): [PMID: 30867162]
  22. Arthritis Care Res (Hoboken). 2014 Jul;66(7):1016-26 [PMID: 24339395]
  23. Pediatr Transplant. 2015 Mar;19(2):219-28 [PMID: 25523718]
  24. BMC Med Res Methodol. 2010 Mar 08;10:18 [PMID: 20210985]
  25. Rheumatology (Oxford). 2016 Sep;55(9):1664-72 [PMID: 27160278]
  26. PLoS One. 2016 Feb 04;11(2):e0147856 [PMID: 26845680]
  27. Vaccine. 2007 May 16;25(20):3955-61 [PMID: 17383057]
  28. Expert Rev Vaccines. 2019 Aug;18(8):859-865 [PMID: 31318303]
  29. Eur J Cancer. 2017 May;76:134-143 [PMID: 28324748]
  30. Clin Trials. 2007;4(3):245-53 [PMID: 17715249]
  31. Vaccine. 2003 Sep 8;21(25-26):3629-37 [PMID: 12922092]
  32. Brain Behav Immun. 2014 Jul;39:33-41 [PMID: 24126151]
  33. J Rheumatol. 2018 Jun;45(6):733-744 [PMID: 29545454]
  34. Clin Med Insights Oncol. 2014 May 01;8:57-64 [PMID: 24855405]
  35. Lancet Infect Dis. 2007 Oct;7(10):667-74 [PMID: 17897609]
  36. Expert Rev Vaccines. 2019 Jul;18(7):737-750 [PMID: 31265333]
  37. Hum Vaccin Immunother. 2018 Mar 4;14(3):637-646 [PMID: 28617077]
  38. Expert Rev Clin Pharmacol. 2013 Jul;6(4):403-11 [PMID: 23927668]
  39. Int J Evid Based Healthc. 2015 Sep;13(3):132-40 [PMID: 26360830]
  40. Evid Based Ment Health. 2018 Aug;21(3):95-100 [PMID: 30006442]
  41. J Infect Dis. 1978 Feb;137(2):194-6 [PMID: 342641]
  42. Acta Reumatol Port. 2017 Jan-Mar;42(1):8-16 [PMID: 28133957]
  43. Curr Opin Immunol. 2014 Aug;29:38-42 [PMID: 24769424]
  44. Clin Vaccine Immunol. 2014 Sep;21(9):1253-60 [PMID: 24990904]
  45. PLoS Pathog. 2011 Dec;7(12):e1002344 [PMID: 22241978]
  46. J Infect Dis. 2019 Apr 19;219(10):1525-1535 [PMID: 30551178]
  47. MMWR Recomm Rep. 2018 Aug 24;67(3):1-20 [PMID: 30141464]
  48. J Hyg (Lond). 1972 Dec;70(4):767-77 [PMID: 4509641]
  49. Ann Intern Med. 2013 Jan 1;158(1):19-26 [PMID: 23277897]
  50. Expert Rev Vaccines. 2018 Jun;17(6):547-554 [PMID: 29882438]
  51. Dev Biol (Basel). 2003;115:63-73 [PMID: 15088777]
  52. Hum Vaccin Immunother. 2018;14(8):1853-1866 [PMID: 29517396]
  53. Hum Vaccin Immunother. 2016 Nov;12(11):2909-2915 [PMID: 27392026]
  54. Clin Vaccine Immunol. 2010 Jul;17(7):1055-65 [PMID: 20463105]
  55. J Clin Epidemiol. 2014 Apr;67(4):368-75 [PMID: 24581293]
  56. Immunol Res. 2014 Dec;60(2-3):277-88 [PMID: 25381481]
  57. Vaccine. 2014 Mar 26;32(15):1661-9 [PMID: 24513009]
  58. Euro Surveill. 2018 Apr;23(16): [PMID: 29692315]
  59. PLoS One. 2013;8(2):e56974 [PMID: 23451126]
  60. Nutrients. 2018 Mar 26;10(4):null [PMID: 29587438]
  61. Clin Infect Dis. 2019 Oct 30;69(10):1817-1823 [PMID: 31102401]
  62. Med Microbiol Immunol. 2019 Aug;208(3-4):305-321 [PMID: 30949763]
  63. Curr Med Res Opin. 2017 Oct;33(10):1901-1908 [PMID: 28489423]
  64. PLoS One. 2015 Sep 17;10(9):e0138237 [PMID: 26379270]
  65. Hum Vaccin Immunother. 2019;15(5):1021-1030 [PMID: 30614754]
  66. Br J Gen Pract. 2016 Sep;66(650):452-3 [PMID: 27563114]
  67. Arthritis Res Ther. 2014 Dec 23;16(6):506 [PMID: 25587634]
  68. Medicine (Baltimore). 2016 May;95(19):e3637 [PMID: 27175678]

Word Cloud

Created with Highcharts 10.0.0influenzahealthvaccine-inducedimmunogenicityfactorscorrelatesprotectionusedInfluenzasystematicevidenceumbrellareviewtotalusevaccinationordervaccinesSeasonalleadinginfectiousdiseasetermssocioeconomicimpactAnnualimmunizationefficientwayreduceburdenSeveralcommonlyowingreadyavailabilitycheapnessfunctionhost-virus-vaccine-relatedHost-relatedconstituteheterogeneousgroupobjectivestudyanalyzeavailablehostablemodifyapproachundertaken28reviews/meta-analysesanalyzed-thesecoveredfollowingdomains:intravenousdrugpsychologicalstressacutechronicphysicalexercisegeneticpolymorphismspre-/pro-/symbioticspreviousBacillusCalmette-GuérindiabetesmellitusvitaminDsupplementation/deficiencylatentcytomegalovirusinfectionvariousformsimmunosuppressionpresenteffectsizesscalepossiblemeta-analysesre-performedcumulativesynthesisrankingcarriedmeta-analysisconductedseparatelyconditioncategoryvirussubtype97pooledestimatesconstructevidence-basedstakeholder-friendlymapprincipalpublicimplicationsdiscussedMappingHost-RelatedCorrelatesVaccine-InducedImmuneResponse:UmbrellaReviewAvailableSystematicReviewsMeta-Analyseshemagglutinationinhibition

Similar Articles

Cited By